Crossmark

Diagnostic utility of serum TRACP5b for secondary osteoporosis in ankylosing spondylitis: a comparative cross-sectional study with primary osteoporosis and healthy controls

Crossref DOI link: https://doi.org/10.1007/s10067-026-07966-7

Published Online: 2026-02-17

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kamal, Doaa https://orcid.org/0000-0001-6299-5144
Fathi, Nihal https://orcid.org/0000-0001-5940-0007
Osman, Asmaa Osama B. S.

Abdalmageed, Amira Mohammad

Galal, Marwa A. A. https://orcid.org/0000-0001-6101-9141
Funding

Funding for this research was provided by:

Assiut University
License Information

Text and Data Mining valid from 2026-02-17

Version of Record valid from 2026-02-17
More Information

Article History

Received: 18 September 2025

Revised: 20 January 2026

Accepted: 22 January 2026

First Online: 17 February 2026

Declarations

:

: This study has been approved by Assiut University Medical Ethical Review Board (IRB no. 17101702) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The study was registered at Clinical trial gov. (NCT 03747354).

: Written informed consent was obtained from all patients prior to their inclusion in the study. All samples were obtained according to the guidelines approved by the Medical Ethical Committee of Assiut University.

: Not applicable.

: All authors declare that they have no competing interests.

Document is current

Any future updates will be listed below